histidine has been researched along with Thromboembolism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Furie, B; Huang, M; Lin, L; Liu, Z; Meehan, EJ; Nicolaes, GA; Yuan, C | 1 |
| Johnsen, AH; Lind, B; Thorsen, S | 1 |
| Beresford, CH; Carrell, RW; Owen, MC | 1 |
3 other study(ies) available for histidine and Thromboembolism
| Article | Year |
|---|---|
Trp2313-His2315 of factor VIII C2 domain is involved in membrane binding: structure of a complex between the C2 domain and an inhibitor of membrane binding.
Topics: Blood Coagulation; Cell Membrane; Crystallography, X-Ray; Factor VIII; Histidine; Humans; Models, Molecular; Phospholipids; Protein Binding; Protein Structure, Tertiary; Risk; Surface Plasmon Resonance; Thromboembolism; Tryptophan; von Willebrand Factor | 2010 |
Naturally occurring Arg(-1) to His mutation in human protein C leads to aberrant propeptide processing and secretion of dysfunctional protein C.
Topics: Amino Acid Sequence; Antimicrobial Cationic Peptides; Arginine; Disease Susceptibility; Histidine; Humans; Male; Middle Aged; Peptides; Point Mutation; Protein C; Protein C Deficiency; Protein Precursors; Protein Processing, Post-Translational; Thromboembolism | 1997 |
Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity.
Topics: Adult; Amino Acid Sequence; Antithrombin III; Arginine; Binding Sites; Heparin; Histidine; Humans; Male; Thrombin; Thromboembolism | 1988 |